This episode of Expert Answers features Dr. Marcela Maus, Director of Cellular Immunotherapy at Mass General Cancer Center and Associate Professor of Medicine at Harvard Medical School. Dr. Maus recently joined us for a webinar about engineering T cells for cancer where she discussed the components and technologies used in making a  T cell product, important factors that contribute to their efficacy, and underlying mechanisms of toxicity and resistance.

For more information or to watch the webinar, click here.